WITHDRAWN: Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction.

@article{Homs2010WITHDRAWNCF,
  title={WITHDRAWN: Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction.},
  author={Marjolein Y V Homs and Ate van der Gaast and Peter D. Siersema and Ewout Willem Steyerberg and Ernst J Kuipers},
  journal={The Cochrane database of systematic reviews},
  year={2010},
  volume={5},
  pages={CD004063}
}
BACKGROUND More than 50% of patients with esophageal cancer have metastatic disease at presentation. The use of chemotherapy for this patient group is increasing with the intention of local and distant tumor control, improving quality of life and prolongation of survival. OBJECTIVES To assess the effectiveness of a) chemotherapy versus best supportive… CONTINUE READING